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GP73 is a novel type II Golgi transmembrane protein that is expressed at high levels in the hepatocytes of patients with
viral hepatitis (R. D. Kladney, G. A. Bulla, L. Guo, A. L. Mason, A. E. Tollefson, D. J. Simon, Z. Koutoubi, and C. J. Fimmel, 2000,
Gene 249, 53–65) and is induced in cultured cells by infection with viruses including adenoviruses. Its biological function and
the mechanisms by which its expression may be regulated by viral infection are unknown. Here we report that GP73 is
induced at the RNA and protein level in human Hep3B hepatoma cells infected by human Ad5 and Ad2. Hep3B cells were
infected with wild-type or mutant adenoviruses. GP73 expression was measured by RNase protection assay, immunoblotting,
or immunofluorescence microscopy. GP73 RNA and protein levels were strikingly induced following infection. The rise in
GP73 expression coincided with the appearance of the adenovirus E1A and DBP proteins and preceded the expression of
the fiber protein, a marker of the late phase of infection. Infection did not affect the expression of giantin, GPP130, or
golgin-84, three integral Golgi membrane proteins with structural similarities to GP73. Mapping studies using a panel of
mutant adenoviruses demonstrated that the E1A C-terminus, specifically its CtBP interaction domain (CID), is required for
GP73 expression. Subsequently, Hep3B cells were transiently transfected with plasmids expressing wild-type or mutant E1A
proteins. These studies confirmed that E1A induced GP73 expression via the CID. Our studies establish GP73 as a novel
adenovirus-induced cellular protein whose expression is regulated through the CID of the E1A protein. © 2002 ElsevierINTRODUCTION
Adenovirus (Ad) infection initiates a complex cascade
of intracellular events in the host cell (Shenk, 1996). The
early phase of infection is characterized by the expres-
sion of early Ad genes including the E1A immediate early
transcriptional regulator. The late phase which follows
the initiation of Ad DNA replication is characterized by
the expression of Ad late genes required for assembly of
new infectious virions and shutdown of host cell macro-
molecular synthesis. The molecular mechanisms by
which early Ad genes subvert the host cell transcrip-
tional machinery during the early stage of infection have
been elucidated over the past decades. For E1A, specific
domains have been identified that interact with cellular
transcription factors to direct viral gene expression, de-
regulate the cell cycle, and modify critical intracellular
signaling cascades, including interferon, STAT, NFB,
IRF-3 and IRF-7, ATF2, c-jun, and other pathways (de-
Groot et al., 1995; Look et al., 1998; Wathelet et al., 1998).
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infection, the majority of host cell genes are not directly
affected by the infection (Zantema and van der Eb, 1995).
However, a few endogenous proteins have been shown
to be expressed at high levels in response to infection.
These include heat shock proteins (Glotzer et al., 2000;
Nevins, 1982; Simon et al., 1987), cyclins (Spitkovsky et
al., 1994), and -tubulin (Stein and Ziff, 1984). In most
cases, the biological role for this upregulation is unclear.
GP73 is a recently identified type II Golgi membrane
protein that is expressed in hepatocytes of patients with
adult giant-cell hepatitis, a severe form of hepatitis with
a presumed viral etiology (Kladney et al., 2000), as well
as in patients with liver disease due to chronic HBV- or
HCV-infection (Kladney et al., 2002). The function of GP73
is unknown, but its expression pattern in human liver
disease suggests that it might be involved in the cellular
response to virus infection.
In the present study, we report that GP73 is strikingly
upregulated in response to Ad infection of cultured
Hep3B hepatoma cells. GP73 induction is dependent
upon the C-terminus of the E1A protein, and specifically,Science (USA)
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its C-terminal binding protein (CtBP) interaction domain
(CID). To our knowledge, GP73 is the first cellular genetransfe© 2002 Elsevier Science (USA) 236
shown to be upregulated through this particular domain
of E1A.
RESULTS
Adenovirus infection induces GP73 expression in
human Hep3B cells
We had previously reported that Ad infection increases
GP73 levels in HepG2 hepatoma cells (Kladney et al.,
2000). GP73 levels were monitored at 24 h postinfection
(p.i.), a period well into the late stages of infection. To
determine whether an Ad early protein is responsible for
induction of GP73, we have now examined GP73 in cells
infected in the presence of Ara-C. Ara-C inhibits Ad DNA
replication and therefore maintains the infection in the
early phase. Hep3B cells were mock-infected or infected
with the rec700 wild-type Ad in the presence of 20 g/ml
Ara-C (Thomas and Matthews, 1980). At 24 h p.i., cellular
RNA and proteins were separately extracted and ana-
lyzed for the GP73 mRNA and protein. Similar to our
previous observation in HepG2 cells (Kladney et al.,
2000), uninfected Hep3B cells expressed barely detect-
able levels of GP73 (Fig. 1A). In contrast, rec700 infection
was associated with a marked upregulation of GP73
expression, both at the mRNA and at the protein level.
The expression of GP73 in the presence of Ara-C sug-
gests that this effect occurs during the early phase of
infection, independent of Ad DNA replication. Immuno-
fluorescence studies demonstrated specific GP73 reac-
tivity in rare, mock-infected cells (Fig. 1B). Approximately
5% of cells spontaneously expressed GP73 (data not
shown). In comparison, essentially all rec700-infected
cells displayed GP73 fluorescence at 24 h p.i. Further-
more, the signal intensity in rec700-infected cells was
strikingly increased as compared to the mock-infected
cells. The pattern of GP73 immunoreactivity was punc-
tate with a perinuclear accentuation, typical of the Golgi
pattern in cultured hepatoma cells. Coexpression exper-
iments using giantin, a Golgi marker protein, confirmed
that the GP73 immunoreactivity was entirely localized to
the Golgi compartment (data not shown). Omission of
Ara-C in mock infections did not affect the GP73 fluores-
cence signals (data not shown).
GP73 expression is a feature of early adenovirus
infection
The finding that GP73 expression could be induced by
rec700 infection in the presence of Ara-C suggests that
GP73 is induced during the early stages of infection. To
relate the expression of GP73 to the time course of Ad
infection, we compared GP73 expression in rec700-in-
fected cells with that of the E1A, DNA-binding protein
(DBP), and fiber proteins. E1A and DBP are first pro-
duced in early infection, whereas fiber is expressed
during the late stage of infection after the initiation of Ad
DNA replication. This experiment was performed in the
absence of Ara-C to allow the infection to progress into
the late stage. GP73 and viral proteins were detected by
immunofluorescence microscopy; the number of Hep3B
cells expressing the respective proteins was calculated
as a function of time postinfection. As demonstrated in
Fig. 2, E1A was present at 5 h p.i. and reached a plateau
of 90% of nuclei E1A-positive by 14 h p.i. DBP was first
detected at 9 h p.i. and rose steadily until 24 h p.i. when
90% of all nuclei were positive. GP73 expression was
present in a small percentage (5%) of cells at the
earliest time points following infection; this was compa-
rable to the background expression seen in mock-in-
fected cells (see above). A definitive increase in the
percentage of GP73-positive cells was noted at 14 h p.i.
The percentage of GP73-expressing cells continued to
rise steadily until 24 h p.i., when approximately 90% of
the cells stained positive. In comparison, a definitive
increase in the percentage of fiber-positive cells became
evident only at 20–24 h p.i. These data suggest that the
increased GP73 expression is a feature of early Ad
infection.
Adenovirus infection does not affect the expression
of other Golgi membrane proteins
To determine whether the effect of rec700 infection
was specific to GP73 or instead representative of a
generalized upregulation of Golgi membrane proteins,
the expression of three resident Golgi membrane pro-
teins, giantin, GPP130, and golgin-84, was examined.
Giantin is a C-terminally anchored Golgi transmembrane
protein (Linstedt and Hauri, 1993) that was previously
found to colocalize with GP73 in 293 cells (Kladney et al.,
2000). GPP130 is a type II membrane protein with gen-
eral structural similarities to GP73, including the pres-
ence of a large, acidic C-terminal domain with two
coiled-coil motifs and a short cytoplasmic N-terminal
domain (Linstedt et al., 1997). Golgin-84 is a type I inte-
gral membrane protein with a large cytoplasmic N-ter-
minus containing a coiled-coil domain and a small lume-
nal C-terminal domain (Bascom et al., 1999). The expres-
sion of the Golgi marker proteins was determined by
Western blotting (Fig. 3A) and immunofluorescence mi-
croscopy (Fig. 3B). As demonstrated in Fig. 3A, giantin,
GPP130, and golgin-84 signals were readily apparent in
mock-infected Hep3B cells. No changes in expression
levels were evident in rec700-infected cells. The immu-
nofluorescence images (Fig. 3B) demonstrated similar
Golgi expression patterns and signal intensities for the
three proteins in mock-infected and rec700-infected
cells. These data suggest that the changes observed
with GP73 are not due to a general effect of Ad infection
on the expression of Golgi membrane proteins.
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FIG. 1. Adenovirus infection elicits GP73 expression in human Hep3B hepatoma cells. Cells were mock-infected or infected with rec700 wild-type
Ad in the presence of Ara-C (20 g/ml) for 24 h. GP73 mRNA and protein levels were measured by ribonuclease protection assay (RPA) and Western
blotting, respectively. GP73 immunofluorescence was detected using a rabbit polyclonal primary antibody directed against GP73 and a goat
anti-rabbit IgG/Alexa Fluor 488 secondary antibody (Molecular Probes). (A) Top: Representative Western blot of GP73. The GP73 signal is apparent
as a broad band with an approximate molecular size of 73 kDa. Middle: GP73 mRNA levels as measured by RPA. A single protected fragment
represents the GP73 mRNA. Bottom: RPA for GAPDH mRNA (loading control). Equal RNA loading is evident in both samples. (B) Immunofluorescence
detection of GP73 (green fluorescence signal) and corresponding nuclear DNA stain (blue fluorescence signal) in mock-infected and rec700-infected
Hep3B cells. The lens magnification was 100-fold. In mock-infected cells, weak GP73 expression can only be detected in occasional cells. Intense
GP73 fluorescence is uniformly present in rec700-infected cells. GP73 immunoreactivity is predominantly found in a punctate, perinuclear, and
cytoplasmic pattern, typical of Golgi distribution in Hep3B cells.
FIG. 3. Ad infection does not affect the expression of giantin, GPP130, or golgin-84. Cells were mock-infected or infected with rec700 in the presence
of Ara-C (20 g/ml). The expression of giantin, GPP130, and golgin-84 was measured 24 h p.i. by Western blotting or immunofluorescence microscopy.
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GP73 upregulation requires the E1A CtBP interacting
domain
The data shown in Figs. 1 and 2 indicate that GP73
expression is upregulated during the early phase of
infection, indicating that early viral gene functions might
be responsible for this effect. We used a series of mu-
tants defective in specific Ad early genes to determine
whether or not these mutants could elicit GP73 expres-
sion. When necessary, infections were allowed to pro-
ceed for up to 48 h to compensate for variability in the
time courses of infection in certain E1A mutants. As
shown in Fig. 4A, a robust GP73 signal was detected in
Hep3B cells infected with the wild-type strains rec700
and Ad2, respectively, whereas mock-infected cells dem-
onstrated only a minimal signal. Cells infected with the
201.2 mutant (deletion of E1A and E1B) did not express
GP73. In contrast, mutants containing deletions that
were limited to the E1B genes (dl110 [55K] and
dl111[19K]) elicited a robust GP73 response, suggesting
that E1A but not E1B functions were required. Any major
role for the E2 gene was unlikely, given the observation
that GP73 induction in cells infected with the wild-type
virus was not diminished by Ara-C. A nonreplicating Ad
vector lacking the E1A and E1B regions and expressing
only the E3 proteins (Ad/E3) did not induce GP73. Infec-
tion with dl7001 (Ranheim et al., 1993), a mutant with a
complete deletion of E3, was associated with a strong
GP73 signal (data not shown), establishing that E3 func-
tion is dispensable for GP73 expression. Infection with
dl808, a mutant containing a large E4 deletion, did not
diminish GP73 expression, suggesting that E4 gene
function was not required (data not shown). Taken to-
gether, these preliminary mapping studies suggested
that E1A function alone might be necessary for GP73
expression.
We therefore performed more detailed mapping studies
focusing on specific domains within the E1A gene. Ad2/
5pm975 or 12S infections resulted in GP73 levels that were
comparable to wild-type infections (Figs. 4A and 4B), sug-
gesting that conserved region 3 (CR3) function was not
required. A robust GP73 signal was present in dl1101/1107-
infected cells, suggesting that functions of the conserved
regions 1 and 2 (CR1, CR2) were not required. GP73 ex-
pression was not induced in cells infected with dl313, a
mutant with a deletion extending into C-terminus of E1A, or
in cells infected with the 177-9 mutant containing a large
C-terminal deletion in E1A. These data suggest that the E1A
C-terminus is required for GP73 expression. This inter-
pretation is supported by a direct comparison of the E1A
mutant viruses (Fig. 4B). In this experiment, we mea-
sured E1A levels to document that the viral mutants were
functioning as expected and at comparable levels.
rec700, pm975, and 12S infections elicited robust GP73
and E1A signals (Fig. 4B). GP73 expression was strik-
ingly diminished in 177-9- and dl1135-infected cells, even
though E1A expression in dl1135-infected cells was sim-
ilar to that in 12S-infected cells. The molecular size and
signal intensity of E1A in 177-9-infected cells were re-
duced, most likely due to the loss of antigenic C-terminal
epitopes recognized by the M73 monoclonal antibody in
the E1A antibody mixture (Arsenault and Webber, 1993).
However, the reduced E1A signal was not due to a
poorer infection, since 177-9 infection elicited a strong
DBP signal (data not shown). Mutant 177-9 lacks aa
178–238 of the Ad2 243R E1A protein, and dl1135 lacks
aa 225–238 of the Ad5 243R protein; these deleted re-
gions include the CtBP interacting domain (CID). There-
fore, these data suggest that the C-terminal domain of
E1A, and specifically its CID, was required for GP73
expression.
(A) Representative results of an immunoblot experiment. Giantin (top), GPP130 (middle), and golgin-84 (bottom) are present in extracts of
mock-infected cells. No changes in expression levels are evident following rec700 infection. The exposure times of the immunoblots for the individual
proteins varied, and the signal intensities do not reflect the absolute protein levels. (B) Immunofluorescence images. Cells were immunostained for
giantin or GPP130 using mouse monoclonal primary antibodies and a goat anti-mouse IgG/Alexa Fluor 549 secondary antibody. Golgin-84 staining
was performed using a rabbit polyclonal primary antibody and goat anti-rabbit IgG/Alexa Fluor 488 secondary antibody (Molecular Probes).
Immunofluorescence signals for both mock- and rec700-infections display an apparent Golgi distribution. The overall signal intensities are not
affected by Ad infection.
FIG. 2. GP73 expression is induced during the early stages of Ad
infection. Hep3B cells were infected with rec700 and fixed after varying
lengths of time ranging from 5 to 24 h. The expression of GP73 (), E1A
(F), DBP (Œ), and fiber protein (f) was assessed by indirect immuno-
fluorescence. The percentage of cells staining positively for each of the
respective proteins is shown for each time point.
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E1A is sufficient for induction of GP73 and requires
the CID
To unequivocally establish a role of the E1A CID for
GP73 induction, we introduced mutated forms of E1A into
Hep3B cells by transient transfection of plasmid con-
structs and followed GP73 and E1A expression by im-
munofluorescence microscopy. As shown in Fig. 5A,
GP73 (and E1A) expression was negligible in the pUC18
vector-transfected cells. With the 13S- and 12S-trans-
fected cells most cells that expressed E1A also ex-
pressed GP73. In contrast, a minority of 177-9- or dl1135-
transfected cells expressing E1A was positive for GP73.
A quantitative analysis demonstrated that approximately
90% of 13S- or 12S-transfected, E1A-positive cells ex-
pressed GP73, compared to 29 and 26% of cells trans-
fected with plasmids carrying the C-terminal mutations
(Fig. 5B). As mentioned under Materials and Methods,
cells were scored positive even if the fluorescence was
weak, as was the case with the cells transfected with
177-9 and dl1135 plasmids (Fig. 5A). Therefore, the per-
centage values do not reflect the true magnitude of the
difference in the 13S and 12S cells vs the 177-9 and
dl1135 cells. This point is illustrated by the dramatic
difference in GP73 levels observed in the corresponding
infection studies (Fig. 4). The results of this experiment
indicate that E1A is sufficient for GP73 induction and that
the CtBP-interacting domain of E1A is necessary for this
function.
DISCUSSION
Our data indicate that GP73 is a Golgi membrane
protein that is upregulated at the RNA and protein levels
in response to Ad infection. GP73 joins a small group of
cellular proteins that are regulated in a similar fashion.
This group includes certain heat shock proteins, cyclins,
and -tubulin. Until recently, it was unclear whether the
upregulation of these proteins was biologically important
for the virus or the host cell or whether it was simply a
bystander consequence of the viral need to activate
transcription. A recent study by Glotzer (2000) in the
avian Ad model of CELO virus infection provided the first
direct evidence that heat shock protein expression may
be required for productive infection. The authors demon-
strated that the antiapoptotic function of Gam1, a CELO
protein required for viral replication, is dependent on the
expression of hsp70 and hsp40. To our knowledge, no
comparable studies have been carried out for any of the
other Ad-induced cellular genes.
GP73 was first identified in a genetic screen for cel-
lular proteins involved in the development of adult giant-
FIG. 4. Expression of GP73 following Ad infection requires the CID of E1A. Hep3B cells were mock-infected or infected with wild-type or mutant
Ad viruses for 24 or 48 h in the presence of Ara-C (20 g/ml). GP73 expression was measured by Western blotting. (A) Gross mapping of GP73
expression to E1A. The figure is representative of three independent experiments. (B) Detailed mapping GP73 expression to the C-terminus of E1A.
In addition to GP73, E1A protein was measured by Western blotting using a mixture of monoclonal antibodies (Harlow et al., 1985). The molecular
size of E1A is reduced in cells infected with 177-9 virus carrying a large C-terminal deletion mutation (arrow).
240 KLADNEY ET AL.
cell hepatitis, a rare form of hepatitis with a postulated
viral etiology (Fimmel et al., 1998). Subsequently, we
observed that GP73 expression by hepatocytes was
strikingly induced in chronic hepatitis B virus and hepa-
titis C virus infection (Kladney et al., 2002). The absence
of suitable in vitro models of productive HBV and HCV
infection prompted us to explore alternative in vitro mod-
els to study the effect of viral infection on GP73 expres-
sion. Initial studies in human HepG2 hepatoma cells
suggested that Ad infection provided such a model (Klad-
ney et al., 2000).
The present study demonstrates that GP73 expression
is strikingly increased in Hep3B cells following infection
with Ad. Three distinct but structurally related Golgi
membrane proteins were not increased in infection, in-
dicating that the upregulation of GP73 is unlikely to be
due to a general effect of Ad infection on Golgi protein
expression. Time-course studies suggested that GP73
expression requires the function of one or more early Ad
genes. This hypothesis was tested by a series of infec-
tions with Ad viruses containing deletion mutations in
early genes. These studies demonstrated that GP73 ex-
pression required E1A function. Further mapping exper-
iments revealed that the C-terminus of E1A was critical
for this effect, in particular the CID. Some functions of
conserved regions 1 (CR1), 2 (CR2), and 3 (CR3) did not
play a major role, although the slight stimulatory effect of
CID-deleted E1A proteins observed in the transfection
studies (Fig. 5) leaves open the possibility that alternate
domains of E1A might compensate, albeit inefficiently, for
the loss of CID.
The E1A C-terminus has been identified as an impor-
tant regulator of Ad gene expression in a rat tumor
model. Initial studies with viral mutants carrying dele-
tions in this domain demonstrated a dramatic increase in
cell transformation, tumorigenesis, and tumor progres-
sion (Subramanian et al., 1989). A novel cellular protein,
named CtBP, was shown to bind to a highly conserved
amino acid motif (PLDLS) of E1A, the CtBP-interacting
domain (Schaeper et al., 1995). Recent studies have
demonstrated that CtBP is a member of a novel family of
transcriptional co-repressors that recognize PXDLS mo-
tifs in a variety of DNA-binding proteins and that function
as transcriptional co-repressors in Drosophila, Xenopus,
and mammals (Turner and Crossley, 2001). CtBP proteins
bind to a variety of transcription factors, including Dro-
sophila Hairy, Snail, and Kru¨ppel, and the SP1-related
zinc finger protein, mammalian Basic Kru¨ppel-like Fac-
tor/Kru¨ppel-like Factor 3 (BLKF/KLF3). CtBP/E1A interac-
tions result in the expression of epithelial genes such as
desmoglein-2, plakoglobin, and E-cadherin (Fischer and
Quinlan, 1998; Grooteclaes and Frisch, 2000). E1A-medi-
ated de-repression by sequestration of CtBP may have
wide-range effect on cellular genes, as recently demon-
strated by Sundqvist et al. (2001). These authors per-
formed functional knock-out studies in cell lines that
allowed the inducible expression of the CID of E1A and
identified differentially expressed genes by gene array
analysis. They found that the expression of approxi-
mately 7% of the analyzed genes was regulated in a
CID-dependent fashion. Interestingly, the most pro-
nounced effects were observed on genes involved in
cell-cycle regulation, apoptosis, and intracellular com-
munication, including cyclin-dependent kinase 5 activa-
tor, MEKK, PKC-, TRAIL receptor, death domain-contain-
ing protein CRADD, caspase 9-precursor, death-associ-
ated protein kinase 1, and RATS1 (Sundqvist et al., 2001).
We hypothesize that Ad infection, through binding of the
E1A CID to CtBP, results in GP73 expression by a de-
repression mechanism at the GP73 promoter.
A potential additional function for CtBP has recently
been revealed by the work of Corda and colleagues
(Spano et al., 1999; Weigert et al., 1999). These authors
found that CtBP/BARS, a rat homolog of human CtBP1,
has a direct effect on Golgi lipid metabolism. CtBP/BARS
catalyzed the acylation of lysophosphatidic acid to phos-
phatidic acid in pure lipid systems and in Golgi mem-
branes. Ribosylation of CtBP/BARS by Brefeldin A was
associated with the disassembly of the Golgi complex.
These data suggest that CtBP might play a direct, enzy-
matic role in the formation and maintenance of the Golgi
complex and raises the hypothesis that a CID-mediated
interaction between Ad and CtBP at the Golgi apparatus
somehow results in the increased expression of GP73.
To our knowledge, GP73 is the first cellular Golgi
protein shown to be upregulated by Ad infection. Our
studies to date have not demonstrated an obvious func-
tion for GP73, and its structure provides no specific
clues. In principle, Golgi membrane proteins may have
the following four basic functions: (1) posttranslational
modification of proteins, including glycosylation; (2)
transport and sorting of secretory and resident proteins;
(3) establishment and regulation of the Golgi structure;
and (4) specific roles in cell signaling and apoptosis
regulation. The absence of significant homologies or
shared motifs in GP73 with the known Golgi glycosi-
dases argues against the first possibility. The lack of a
significant cytoplasmic domain argues against a role in
vesicle trafficking and tethering (“Velcro function”). Con-
sequently, we are considering the possibility that GP73
functions by interacting with viral or cellular proteins
undergoing modification within the Golgi lumen. The Ad
model established in this article may provide us with a
suitable experimental model to elucidate the role(s) of
GP73 in viral infection.
Our study suggests that the Golgi apparatus might be
a specific target in Ad infection. Precedents for viral
interference with Golgi structure or functions have been
established in studies of HSV 1 (Campadelli et al., 1993;
Ward et al., 1998), poliovirus (Sandoval and Carrasco,
1997), and corona mouse hepatitis virus (Lavi et al.,
1996). Interestingly, early electron microscopic studies
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have hinted at similar morphological alterations in the
Golgi apparatus of Ad-infected cells (Lenk et al., 1980).
In summary, our study establishes GP73 as a novel
protein with upregulated expression in Ad infection. The
upregulation appears to be specific to this particular
Golgi protein and requires the function of the E1A C-
terminus and, specifically, its CID. Its biochemical func-
tion and role in the cellular response to Ad infection
remain to be elucidated.
MATERIALS AND METHODS
Cell lines
Human Hep3B (Hep 3B2.1–7) cells were obtained from
the American Type Culture Collection (ATCC). This cell
line is derived from a hepatocellular cancer and contains
an integrated copy of the hepatitis B virus genome
(Knowles et al., 1980). Hep3B cells resemble normal
hepatocytes by expressing a number of hepatocyte
marker proteins, including alpha fetoprotein, albumin,
-2-macroglobulin, and transferrin (Knowles et al., 1980).
They are considered to be highly differentiated (Kawai et
al., 2001). Hep3B cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (FBS), penicillin, and streptomy-
cin and cultured at 37°C in 95% air and 5% CO2.
Viruses and infection
The Ad2 wild-type (wt) virus was obtained from ATCC.
rec700 is a Ad5-Ad2-Ad5 recombinant that has a wt E1A
region and is used as a wt control (Wold et al., 1986). The
mutant E1A viruses (see Table 1) are named Ad2/
5pm975 (13S only; carrying a deletion in the 12S donor
splice site) (Montell et al., 1982), 12S [Ad5 derivative; 12S
only, conserved region (CR3) transactivation defective]
(Stephens and Harlow, 1987), dl313 (Ad5 derivative;
2350-bp deletion of map units 3.5–10.6, deleting the sec-
ond exon of E1A and E1B) (Jones and Shenk, 1979),
dl201.2 (Ad2 derivative; deletion of map units2–6, E1A-,
E1B-) (Brusca and Ehinnadurai, 1983), dl1101/1107 [Ad5
derivative containing exon 1 deletion of aa 4–25 (dl1101)
and aa 111–163(dl1107), resulting in the inability of E1A
proteins to bind p300 and p105-Rb] (Howe et al., 1990),
dl110 (Ad5 derivative, deletion of bp 2333–2804, resulting
in a truncated form of the 55-kDa protein of E1B) (Babiss
and Ginsberg, 1984), dl111 (derived from the Ad5 mutant
dl309, E1B19K, RID, 14.7K) (Babiss et al., 1984),
177-9 (Ad2 derivative, 12S E1A background, deletion of
aa 178–238 of E1A, defective in CtBP binding) (Subrama-
nian et al., 1989), and dl1135 (Ad5 derivative in a 12S
background; deletion of aa 225–238 of E1A, lacking the
CtBP binding domain) (Arsenault and Webber, 1993; Boyd
et al., 1993). dl808 is an Ad5 derivative that lacks E4
function (1030-bp deletion of map units 92.0–97.1, defec-
tive in E4 subregions 1 or 2 through 7) (Challberg and
Ketner, 1981). All mutants except rec700, dl201.2, 177-9,
and dl808 were derived from the parental virus dl309
which has a deletion in the E3 region that removes the
genes for E3-RID and E3-14.7K. Ad/E3 is an E1-minus
replication-deficient Ad vector with an expression cas-
sette consisting of the E3 genes driven off the CMV
promoter inserted into the E1 region (Tollefson et al.,
2001). The E1A deletion mutants, Ad/E3 and dl808, were
grown in monolayers of human 293 cells (Green and
FIG. 5. GP73 expression is induced by transfection with E1A expression plasmids; induction requires the CID of E1A. Hep3B cells were transfected
with a control plasmid (pUC18) or with plasmids carrying E1A wild-type 13S or 12S genes, the large C-terminal deletion mutation (177-9) of E1A in
a 12S background, or a deletion of the CtBP-binding domain (dl1135) in a 12S E1A background. GP73 protein expression was assessed by
immunofluorescence (green fluorescence signal) using a GP73-specific polyclonal antibody. E1A coexpression was detected using the pooled mouse
monoclonal antibody mix (red fluorescence). Nuclear DNA was visualized using DAPI (blue fluorescence). (A) Representative fluorescence images
from transiently transfected cells. E1A and GP73 signals are absent in pUC18-transfected cells. 13S- and 12S-transfected cells exhibit a marked
increase in GP73 signal, and GP73 and E1A are coexpressed extensively. In comparison, a minority of E1A-expressing cells transfected with the 177-9
or dl1135 plasmids expressed GP73. (B) Quantitation of GP73/E1A coexpression. Immunofluorescence data were quantitated by cell counting and
expressed as the percentage of E1A-positive cells with an unequivocal GP73 signal. Results are shown as means  SEM. Extensive coexpression
of GP73 and E1A was found in 13S- and 12S-transfected cells. In contrast, a minority of cells transfected with 177-9 or dl1135 plasmids coexpressed
GP73.
TABLE 1
Mutant Viruses Used in This Studya
Virus Phenotype [reference]
rec700 Wild-type E1A [Wold et al., 1986]
dl201.2 Lacks E1A and E1B [Brusca and Chinnadurai,
1983]
Ad2/5 pm975 289R only [Montell et al., 1982]
12S 243R only [Stephens and Harlow, 1987]
d/313 Lacks aa 174–243 of the EIA c-terminus (including
CID) [Jones and Shenk, 1979]
dl1101/1107 Defective in CR1 and CR2 [Howe et al., 1990]
177-9 Lacks aa 178–238 of the E1A C-terminus
(including CID)b [Subramanian et al., 1989]
dl1135 Lacks aa 225–238 of the E1A C-terminus
(including CID)b [Arsenault and Webber, 1993],
[Boyd et al., 1993]
dl110 Lacks E1B 55K [Babiss and Ginsberg, 1984]
dl111 Lacks E1B 19K [Babiss et al., 1984]
Ad/E3 E3 proteins only (except ADP) [Tollefson et al.,
2001]
dl808 Lacks E4 [Challberg and Ketner, 1981]
a The following mutants were derived from the parental virus dl309:
Ad2/5 pm975, 12S, dl313, dl1101/1107, d/1135, dl110, dl111.
b 12S background.
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Wold, 1979). Hep3B cells were infected with 100 to 300
PFU of the appropriate virus, and the infection was al-
lowed to proceed for 24 to 48 h prior to harvest. In some
experiments, 1--D-arabinofuranosylcytosine (Ara-C) (20
g/ml) was added to the culture media to prevent ad-
enoviral DNA replication (Thomas and Matthews, 1980).
Transfections
Hep3B cells were transiently transfected with pUC18
vector (Life Technologies, Gaithersburg, MD) or with
pUC18-derived plasmids carrying Ad wt E1A 13S or 12S
genes, or E1A with mutations within the C-terminus
(177-9, dl1135). The terms 13S and 12S refer to the sizes
of E1A-derived mRNAs that encode the 289R and 243R
proteins, respectively. The Hep3B cells were grown to
approximately 75% confluency on six-well plates contain-
ing coverslips. Transfections were carried out using Li-
pofectamine 2000, following the manufacturer’s protocol
(Life Technologies). Aliquots of transfection-grade plas-
mid DNA were diluted in Opti-MEM I Reduced Serum
(Life Technologies). Lipofectamine 2000 was suspended
in Opti-MEM I (1:20 v/v) for 5 min. Aliquots of diluted
plasmid DNA and Lipofectamine 2000 suspension were
combined in microcentrifuge tubes and incubated at
room temperature (RT) for 20 min. Immediately prior to
transfection, culture media was removed from the Hep3B
cells and replaced with Opti-MEM I. Aliquots of plasmid
DNA/Lipofectamine 2000 complex (corresponding to 5
g plasmid DNA and 12.5 l Lipofectamine 2000 per
well) were added to the cells, followed by a 2.5 h incu-
bation at 37°C. The medium was removed and replaced
with DMEM/10% FBS. Cells were incubated for 48–72 h
and then fixed for immunofluorescence microscopy (see
below).
RNase protection assays
Total cellular RNA was isolated from cultured cells
using a rapid, guanidine-based method (RNA Stat 60,
Tel-Test, Friendswood, TX). A cRNA antisense probe di-
rected against the GP73 cDNA was prepared as previ-
ously described (Kladney et al., 2000). Twenty microgram
aliquots of RNA were hybridized to the probe for the
ribonuclease protection assay (RPA) using a commercial
kit (RPAIII, Ambion, Austin, TX). The RPA control probe
was directed against human GAPDH.
Antibodies
GP73 was measured using a polyclonal rabbit anti-
serum raised against recombinant human GP73 (Klad-
ney et al., 2000). Giantin was detected using a rabbit
polyclonal antiserum directed against the N-terminal
moiety of the protein for immunoblotting assays or a
mouse monoclonal antibody for immunofluorescence ex-
periments (Linstedt and Hauri, 1993). GPP130 and gol-
gin-84 were detected using a mouse monoclonal anti-
body or a rabbit polyclonal antiserum against the human
proteins, respectively (Linstedt et al., 1997; Bascom et al.,
1999). E1A was detected with a monoclonal antibody
mixture consisting of pooled supernatants of Harlow M1,
M2, M37, M58, and M73 hybridomas (Harlow et al., 1985).
Adenoviral DNA binding protein (DBP) was detected with
a rabbit polyclonal antibody (Lillie et al., 1987), and fiber
protein was detected with a mouse monoclonal antibody
(generously provided by Jeff Engler).
Western blotting
Hep3B cells were washed three times with PBS fol-
lowed by the addition of lysis buffer (62.5 mM Tris–Cl pH
6.8, 20 mM DTT, 10% glycerol, 1% SDS). Adherent cells
were removed with plastic scrapers, and the lysates
transferred to microcentrifuge tubes. Samples were
boiled for 3 min, sonicated for 30 s, and centrifuged at
14,000 rpm at 4°C for 20 min. The cleared lysates were
stored at 80°C and analyzed in batch fashion. Protein
concentrations of the lysates were determined using a
modification of the micro-Lowry method with bovine se-
rum albumin as a standard (Protein Assay Kit, Sigma, St.
Louis, MO). Aliquots corresponding to 15 g of total
cellular protein were subjected to SDS–PAGE using pre-
cast 10% Tris–HCl gels (Ready Gels, Bio-Rad, Hercules,
CA) in a running buffer containing 25 mM Tris–Cl, 192
mM glycine, and 0.1% SDS. Gels were run at 100 V for 8
min and then at 200 V for 30 min. A control sample
consisting of 7.5 g of total cellular protein from HEK293
cells (ATCC) was included in each gel run. 293 cells were
found to give a robust GP73 protein signal, which was
used as a standard to facilitate quantitative comparisons
between gels. Separated proteins were transferred to
PVDF membranes (PVDF-Plus, Micron Separations,
Westborough, MA) with a semidry transfer cell (Trans-
Blot SD, Bio-Rad), using an optimized buffer (48 mM
Tris–Cl, 39 mM glycine, 0.005% SDS, 20% methanol) and
standardized transfer conditions (10 V, 30 min). Mem-
branes were kept overnight in blocking buffer [10% non-
fat dry milk in Tris-buffered saline (pH 7.6) containing
0.5% Tween 20 (TBST)] at 4°C. They were then washed
three times in wash buffer (0.5% nonfat dry milk in TBST)
and incubated for 1 h at RT in 15 ml of wash buffer
containing primary antibodies. Several washes with
high-salt buffer (0.5% nonfat dry milk in TBST containing
0.5 M NaCl) and wash buffer were then performed. This
was followed by an incubation for 30 min in washing
buffer with 1:1000 v/v preadsorbed anti-rabbit or anti-
mouse IgG-HRP conjugate (Santa Cruz Biotechnology,
Santa Cruz, CA). After repeat washes with high-salt and
wash buffer, GP73 or E1A immunoreactivity was visual-
ized by enhanced chemiluminescence using a commer-
cial kit (ECL, Amersham Pharmacia Biotech, Bucking-
hamshire, U.K.).
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Immunofluorescence microscopy
Hep3B cells were washed with PBS, fixed in 4% para-
formaldehyde in PBS for 10 min at RT, permeabilized
with methanol containing 4,6-diamidino-2-phenylindole
(DAPI) for 6 min at 20°C, and washed with 20°C
methanol without DAPI for 2 min at RT. For GPP130 and
golgin-84 staining, the paraformaldehyde step above
was omitted. After PBS washes, coverslips were incu-
bated with a blocking solution containing 4% (v/v) goat
serum in PBS for 20 min. This was followed by a 1 h
incubation with primary antibodies at RT. After two PBS
washes, coverslips were incubated with secondary an-
tibodies in PBS containing 4% goat serum. Secondary
antibodies were goat anti-mouse IgG/Alexa Fluor 594 or
goat anti-rabbit IgG/Alexa Fluor 488 conjugates (1:400
v/v) (Molecular Probes, Eugene, OR). Following two PBS
washes, coverslips were mounted in elvanol-containing
p-phenylenediamine (Heimer and Taylor, 1974). The im-
ages shown in Fig. 5A were viewed using a Nikon Op-
tiphot-2 microscope equipped with epifluorescence and
photographed using Kodak Elite CHROME 400 film. All
other fluorescent images were captured using a Nikon
DXM1200 digital still camera with ACT-1 software (Nikon,
Tokyo, Japan). The final images were processed using
Photoshop.
Quantitation of immunofluorescent signals
The cellular expression of marker proteins by immu-
nofluorescence microscopy was quantitated by cell
counting. All measurements were performed by one in-
vestigator (C.J.F.). Whenever possible, counting was per-
formed without the investigator’s knowledge of the ex-
perimental condition. All cells in a visual field (counted
by DAPI fluorescence) that were positive for a chosen
marker were included in the counting, regardless of the
signal strength. Typically, 500 to 2000 cells (correspond-
ing to 10 to 40 randomly selected fields, respectively)
were assessed for each data point.
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